Penumbra EBITDA 2014-2025 | PEN
Penumbra annual and quarterly EBITDA history from 2014 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Penumbra EBITDA for the quarter ending June 30, 2025 was $0.046B, a 163.2% decline year-over-year.
- Penumbra EBITDA for the twelve months ending June 30, 2025 was $0.178B, a 2148.8% increase year-over-year.
- Penumbra 2024 annual EBITDA was $0.033B, a 67.28% decline from 2023.
- Penumbra 2023 annual EBITDA was $0.101B, a 231.57% increase from 2022.
- Penumbra 2022 annual EBITDA was $0.03B, a 241.34% increase from 2021.
| Penumbra Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $33 |
| 2023 | $101 |
| 2022 | $30 |
| 2021 | $9 |
| 2020 | $-24 |
| 2019 | $56 |
| 2018 | $5 |
| 2017 | $5 |
| 2016 | $2 |
| 2015 | $6 |
| 2014 | $4 |
| 2013 | $0 |
| Penumbra Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-06-30 | $46 |
| 2025-03-31 | $45 |
| 2024-12-31 | $47 |
| 2024-09-30 | $40 |
| 2024-06-30 | $-73 |
| 2024-03-31 | $20 |
| 2023-12-31 | $42 |
| 2023-09-30 | $20 |
| 2023-06-30 | $25 |
| 2023-03-31 | $15 |
| 2022-12-31 | $11 |
| 2022-09-30 | $12 |
| 2022-06-30 | $6 |
| 2022-03-31 | $2 |
| 2021-12-31 | $-34 |
| 2021-09-30 | $12 |
| 2021-06-30 | $14 |
| 2021-03-31 | $17 |
| 2020-12-31 | $2 |
| 2020-09-30 | $-17 |
| 2020-06-30 | $-12 |
| 2020-03-31 | $4 |
| 2019-12-31 | $13 |
| 2019-09-30 | $15 |
| 2019-06-30 | $15 |
| 2019-03-31 | $13 |
| 2018-12-31 | $8 |
| 2018-09-30 | $-19 |
| 2018-06-30 | $11 |
| 2018-03-31 | $5 |
| 2017-12-31 | $5 |
| 2017-09-30 | $2 |
| 2017-06-30 | $0 |
| 2017-03-31 | $-1 |
| 2016-12-31 | $0 |
| 2016-09-30 | $0 |
| 2016-06-30 | $0 |
| 2016-03-31 | $3 |
| 2015-12-31 | $2 |
| 2015-09-30 | $3 |
| 2015-06-30 | $-3 |
| 2015-03-31 | $4 |
| 2014-12-31 | |
| 2014-09-30 | $0 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $10.038B | $1.195B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $183.063B | 22.15 |
| Intuitive Surgical (ISRG) | United States | $172.911B | 71.67 |
| IDEXX Laboratories (IDXX) | United States | $53.117B | 55.28 |
| Edwards Lifesciences (EW) | United States | $45.606B | 30.23 |
| Alcon (ALC) | Switzerland | $42.656B | 28.83 |
| IQVIA Holdings (IQV) | United States | $32.339B | 18.27 |
| DexCom (DXCM) | United States | $31.357B | 47.03 |
| Mettler-Toledo (MTD) | United States | $27.274B | 32.37 |
| STERIS (STE) | Ireland | $24.334B | 25.90 |
| Waters (WAT) | United States | $17.669B | 24.27 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.740B | 0.00 |
| Hologic (HOLX) | United States | $15.342B | 16.62 |
| Sysmex ADR (SSMXY) | Japan | $8.699B | 27.64 |
| Globus Medical (GMED) | United States | $8.500B | 19.56 |
| Masimo (MASI) | United States | $8.473B | 28.51 |
| Teleflex (TFX) | United States | $5.432B | 8.77 |
| Glaukos (GKOS) | United States | $5.264B | 0.00 |
| TransMedics (TMDX) | United States | $4.501B | 68.42 |
| Integer Holdings (ITGR) | United States | $3.839B | 19.16 |
| LivaNova (LIVN) | United Kingdom | $2.897B | 16.58 |
| Veracyte (VCYT) | United States | $2.414B | 33.35 |
| Alphatec Holdings (ATEC) | United States | $2.338B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.247B | 0.00 |
| Artivion (AORT) | United States | $2.063B | 104.12 |
| Nihon Kohden (NHNKY) | Japan | $2.052B | 24.49 |
| Elekta AB (EKTAY) | Sweden | $1.874B | 16.84 |
| Pulse Biosciences (PLSE) | United States | $1.130B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.100B | 6.30 |
| OPKO Health (OPK) | United States | $1.072B | 0.00 |
| IRadimed (IRMD) | United States | $0.903B | 43.83 |
| Tandem Diabetes Care (TNDM) | United States | $0.752B | 0.00 |
| AxoGen (AXGN) | United States | $0.679B | 0.00 |
| SiBone (SIBN) | United States | $0.677B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.656B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.552B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.527B | 4.23 |
| OrthoPediatrics (KIDS) | United States | $0.504B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.499B | 8.81 |
| Treace Medical Concepts (TMCI) | United States | $0.436B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.389B | 92.58 |
| Pacific Biosciences Of California (PACB) | United States | $0.384B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.381B | 9.69 |
| AngioDynamics (ANGO) | United States | $0.368B | 0.00 |
| RxSight (RXST) | United States | $0.340B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.339B | 0.00 |
| NeuroPace (NPCE) | United States | $0.308B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.290B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.289B | 19.92 |
| Neuronetics (STIM) | United States | $0.256B | 0.00 |
| 908 Devices (MASS) | United States | $0.253B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.226B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.223B | 0.00 |
| Inogen (INGN) | United States | $0.208B | 0.00 |
| CVRx (CVRX) | United States | $0.202B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.191B | 0.00 |
| Accuray (ARAY) | United States | $0.168B | 0.00 |
| LENSAR (LNSR) | United States | $0.152B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.146B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.144B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.138B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.128B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.106B | 0.00 |
| InspireMD (NSPR) | United States | $0.104B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.102B | 0.00 |
| Hyperfine (HYPR) | United States | $0.099B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.088B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.057B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.056B | 0.00 |
| Positron (POSC) | United States | $0.056B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.018B | 0.00 | |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.14 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |